CYTOVAC A/S: Financial statements 2015
CVR: 31262666
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -9,151,897 and a net result of DKK -12,228,026 compared with DKK -10,783,238 the year before. Equity in the 2015 report amounted to DKK 5,921,516. The solvency ratio was 69.1%.
- Gross Profit
- DKK -9,151,897
- Profit/Loss
- DKK -12,228,026
- Equity
- DKK 5,921,516
- Total Assets
- DKK 8,571,879
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -9.2M | -12.2M | 5.9M | - |
| 2014 | - | -8.1M | -10.8M | 18.1M | - |
| 2013 | - | -6.6M | -10.9M | 1.9M | - |
| 2012 | - | -5.2M | -10.9M | 12.8M | - |
Official annual report
How creditworthy is CYTOVAC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of June 15, 2015, Ole Sylvester-Hvid Wiborg has left the board of directors of CYTOVAC A/S.
CYTOVAC A/S has published its annual report for 2014. Gross profit came to DKK -8,077,959, and the net result was DKK -10,783,238.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.